BioNTech SE (BNTX) Enterprise Value (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.74% |
| Sep 30, 2025 | -8.84% |
| Jun 30, 2025 | -9.70% |
| Mar 31, 2025 | 27.90% |
| Dec 31, 2024 | 3.02% |
| Sep 30, 2024 | -2.89% |
| Jun 30, 2024 | -0.37% |
| Mar 31, 2024 | 1.22% |
| Dec 31, 2023 | -12.93% |
| Sep 30, 2023 | -7.53% |
| Jun 30, 2023 | -7.61% |
| Mar 31, 2023 | -7.65% |
| Dec 31, 2022 | -51.60% |
| Sep 30, 2022 | -43.79% |
| Jun 30, 2022 | -236.88% |
| Mar 31, 2022 | 17.65% |
| Dec 31, 2021 | -66.27% |
| Sep 30, 2021 | 2.07% |
| Jun 30, 2021 | 100.00% |
| Mar 31, 2021 | -90,867,924.18% |
| Dec 31, 2019 | -11.73% |
| Dec 31, 2018 | -134.34% |